Skip to main content
SpringerLink
Log in

A Novel Combination of Methotrexate and Epigallocatechin Attenuates the Overexpression of Pro-inflammatory Cartilage Cytokines and Modulates Antioxidant Status in Adjuvant Arthritic Rats

  • Published:
Inflammation Aims and scope Submit manuscript

Abstract

The present study was designed to evaluate the combinatory effect of methotrexate (MTX) and epigallocatechin (EGCG) on the progression of adjuvant-induced arthritis in rats. Adjuvant arthritis (AA) was induced by a single intradermal injection of Freund’s complete adjuvant. AA rats were treated with methotrexate (0.3 mg/kg) thrice a week, EGCG (100 mg/kg) daily, and combination of MTX and EGCG thrice a week for a period of 28 days. Paw swelling changes and histopathological and radiographic analysis was assessed to evaluate the antiarthritic effect. Lipid peroxidation and antioxidant enzyme activities in joint tissue homogenate were performed to observe the modulation of antioxidant status along the expression of different pro-inflammatory cartilage cytokines like TNF-α and IL-6. MTX and EGCG combination potentiated both the antiarthritic (decrease of hind paw volume) and the antioxidant effect (SOD, GSH, and catalase) as well as suppression of lipid peroxidation. Combination therapy of MTX and EGCG significantly inhibited the development phase of arthritis, which is supported by histopathological, radiographical, and attenuation of overexpression of cartilage cytokines. EGCG act as potent antioxidant and immunomodulator, suggesting that combined administration of MTX along with EGCG suppressed the development phase of arthritic progression in rats.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1
Fig. 2
Fig. 3
Fig. 4
Fig. 5
Fig. 6

Similar content being viewed by others

REFERENCES

  1. Firestein, G.S. 2003. Evolving concept of rheumatoid arthritis. Nature 423: 356–361. doi:10.1038/nature01661. PMID: 12748655.

    Article  PubMed  CAS  Google Scholar 

  2. Mathew, A.J., J. Antony, S. Eremenco, B.V. Paul, B. Jayakumar, and J. Philip. 2009. Health-related quality of life in rheumatoid arthritis patients in South India. Singapore Medical Journal 50: 800–803. PMID: 19710980.

    PubMed  CAS  Google Scholar 

  3. Wortmann, R.L. 1991. Pathogenesis of rheumatoid arthritis: Basis for future therapies. Seminars in Arthritis and Rheumatism 21(suppl): 35–39. PMID: 1749947.

    Article  PubMed  CAS  Google Scholar 

  4. Zvaifler, N.J. 1988. New perspectives on the pathogenesis of rheumatoid arthritis. American Journal of Medicine 85(suppl): 12–17. PMID: 3052052.

    Article  PubMed  CAS  Google Scholar 

  5. Hassan, M.Q., R.A. Hadi, Z.S. Al-Rawi, V.A. Padron, and S.J. Stohs. 2001. The glutathione defense system in the pathogenesis of rheumatoid arthritis. Journal of Applied Toxicology 21: 69–73. doi:10.1002/jat.736. PMID: 11180282.

    Article  PubMed  CAS  Google Scholar 

  6. Heliovaara, M., P. Knekt, K. Aho, R.K. Aaran, G. Alfthan, and A. Aromaa. 1994. Serum antioxidants and risk of rheumatoid arthritis. Annals of the Rheumatic Diseases 53: 51–53. PMID: 8311556.

    Article  PubMed  CAS  Google Scholar 

  7. Jaswal, S., H.C. Mehta, A.K. Sood, and J. Kaur. 2003. Antioxidant status in rheumatoid arthritis and role of antioxidant therapy. Clinica Chimica Acta 338: 123–129. PMID: 14637276.

    Article  CAS  Google Scholar 

  8. Feldmann, M., F.M. Brennan, and R.N. Maini. 1996. Role of cytokines in rheumatoid arthritis. Annual Review of Immunology 14: 397–440. doi:10.1146/annurev.immunol.14.1.397. PMID: 8717520.

    Article  PubMed  CAS  Google Scholar 

  9. Chu, C.Q., M. Field, M. Feldmann, and R.N. Maini. 1991. Localization of tumor necrosis factor alpha in synovial tissues and at the cartilage-pannus junction in patients with rheumatoid arthritis. Arthritis and Rheumatism 34: 1125–1232. PMID: 1930331.

    Article  PubMed  CAS  Google Scholar 

  10. Farahat, M.M., G. Yanni, R. Poston, and G.S. Panayi. 1993. Cytokine expression in synovial membrane of patients with rheumatoid arthritis & osteoarthritis. Annals of the Rheumatic Diseases 52: 870–875. PMID: 8311538.

    Article  PubMed  CAS  Google Scholar 

  11. Nishimoto, N. 2006. Interleukin-6 in rheumatoid arthritis. Current Opinion in Rheumatology 18: 277–281. PMID: 16582692.

    Article  PubMed  CAS  Google Scholar 

  12. Akira, S., T. Taga, and T. Kishimoto. 1993. Interleukin-6 in biology and medicine. Advances in Immunology 54: 1–78. PMID: 8379461.

    Article  PubMed  CAS  Google Scholar 

  13. Kishimoto, T. 2005. IL-6: From laboratory to bedside. Clinical Reviews in Allergy & Immunology 28: 177–186. doi:10.1385/CRIAI:28:3:177. PMID: 16129902.

    Article  CAS  Google Scholar 

  14. Benslay, D.N., and A.M. Bendele. 1991. Development of a rapid screen for detecting and differentiating immunomodulatory vs anti-inflammatory compounds in rats. Agents and Actions 34: 254–256. PMID: 1793040.

    Article  PubMed  CAS  Google Scholar 

  15. Halloran, M.M., J.M. Woods, Z. Szekanecz, N. Barquin, G.K. Haines, A. Walz, and A.E. Koch. 1999. The role of an epithelial neutrophil-activating peptide-78-like protein in rat adjuvant-induced arthritis. Journal of Immunology 162: 7492–7500. PMID: 10358204.

    CAS  Google Scholar 

  16. Billiau, A., and P. Matthys. 2001. Modes of action of Freund’s adjuvants in experimental models of autoimmune diseases. Journal of Leukocyte Biology 70: 849–860. PMID: 11739546.

    PubMed  CAS  Google Scholar 

  17. Braun, J., and R. Rau. 2009. An update on methotrexate. Current Opinion in Rheumatology 21: 216–223. PMID: 19373092.

    Article  PubMed  CAS  Google Scholar 

  18. Cronstein, B.N. 2005. Low-dose methotrexate: A mainstay in the treatment of rheumatoid arthritis. Pharmacological Reviews 57: 163–172. doi:10.1124/pr.57.2.3. PMID: 15914465.

    Article  PubMed  CAS  Google Scholar 

  19. Joannides, A.J., H. El-Shaboury, R. Guirguis, J.J. Fasler, and V. Rajagopal. 2011. Methotrexate-associated lymphoproliferative disorder presenting as disseminated malignancy. Rheumatology 50: 1927–1928. doi:10.1093/rheumatology/ker214. PMID: 21719419.

    Article  PubMed  CAS  Google Scholar 

  20. MCkendry, R.J., and P. Dale. 1993. Adverse effects of low dose methotrexate therapy in rheumatoid arthritis. Journal of Rheumatology 20: 1850–1856. PMID: 8308769.

    PubMed  CAS  Google Scholar 

  21. Smolen, J.S., D. Aletaha, J.W. Bijlsma, F.C. Breedveld, D. Boumpas, G. Burmester, B. Combe, M. Cutolo, M. de Wit, M. Dougados, P. Emery, A. Gibofsky, J.J. Gomez-Reino, B. Haraoui, J. Kalden, E.C. Keystone, T.K. Kvien, I. McInnes, E. Martin-Mola, C. Montecucco, M. Schoels, and D. van der Heijde. 2010. Treating rheumatoid arthritis to target: Recommendations of an international task force. Annals of the Rheumatic Diseases 69: 631–637. doi:10.1136/ard.2009.123919. PMID: 20215140.

    Article  PubMed  Google Scholar 

  22. Weinblatt, M.E., J.M. Kremer, A.D. Bankhurst, K.J. Bulpitt, R.M. Fleischmann, R.I. Fox, C.G. Jackson, M. Lange, and D.J. Burge. 1999. A trial of etanercept, a recombinant tumor necrosis factor receptor: Fc fusion protein, in patients with rheumatoid arthritis receiving methotrexate. The New England Journal of Medicine 340: 253–259. PMID: 9920948.

    Article  PubMed  CAS  Google Scholar 

  23. Trevisanato, S.I., and Y.I. Kim. 2000. Tea and health. Nutrition Reviews 58: 1–10. PMID: 10697388.

    Article  PubMed  CAS  Google Scholar 

  24. Yang, C.S., and Z.Y. Wang. 1993. Tea and cancer. Journal of the National Cancer Institute 85: 1038–1049. doi:10.1093/jnci/85.13.1038. PMID: 8515490.

    Article  PubMed  CAS  Google Scholar 

  25. Katiyar, S.K., and C.A. Elmets. 2001. Green tea polyphenolic antioxidants and skin photo protection. International Journal of Oncology 18: 1307–1313. PMID: 11351267.

    PubMed  CAS  Google Scholar 

  26. Lin, Y.L., and J.K. Lin. 1997. Epigallocatechin-3-gallate blocks the induction of nitric oxide synthase by downregulating lipopolysaccharide-induced activity of transcription factor nuclear factor-kappaB. Molecular Pharmacology 52: 465–472. PMID: 9281609.

    PubMed  CAS  Google Scholar 

  27. Sachinidis, A., R.A. Skach, C. Seul, Y. Ko, J. Hescheler, H.Y. Ahn, and J. Fingerle. 2002. Inhibition of the PDGF beta-receptor tyrosine phosphorylation and its downstream intracellular signal transduction pathway in rat and human vascular smooth muscle cells by different catechins. The FASEB Journal 16: 893–895. PMID: 12039871.

    CAS  Google Scholar 

  28. Mukhtar, H., and N. Ahmad. 2000. Tea Polyphenols: Prevention of cancer and optimizing health. American Journal of Clinical Nutrition 71: 1698S–1702S. PMID: 10837321.

    PubMed  CAS  Google Scholar 

  29. Constantin, A., P. Loubet-lescoulie, N. Lambert, and A. Cantagrel. 1998. Anti-inflammatory and immunoregulatory action of methotrexate in the treatment of rheumatoid arthritis: Evidence of increased interleukin-4 and interleukin-10 gene expression demonstrated in vitro by competitive reverse transcriptase-polymerase chain reaction. Arthritis and Rheumatism 41: 48–57. doi:10.1002/1529-0131(199801)41. PMID: 9433869.

    Article  PubMed  CAS  Google Scholar 

  30. Chesbrough, M., and J. McArthur. 1972. Laboratory manual of rural tropical hospitals. Churchil: The English Language Book Society.

    Google Scholar 

  31. David, G., and A.J. Sykes. 1951. Westergren and Wintrobe methods of estimating ESR compared. British Medical Journal 2: 1496–1497. PMID: 14886634.

    Article  Google Scholar 

  32. Balasubramaniam, P., and A. Malathi. 1992. Comparative study of hemoglobin estimated by Drabkin’s and Sahli’s methods. Journal of Postgraduate Medicine 38: 8–9. PMID: 1512732.

    PubMed  CAS  Google Scholar 

  33. Okhawa, H., N. Oishi, and K. Yagi. 1979. Assay for lipid peroxides in animal tissue by thiobarbituric acid reaction. Analytical Biochemistry 95: 351–358. PMID: 36810.

    Article  Google Scholar 

  34. Ellman, G.L. 1959. Tissue sulphydril groups. Archives of Biochemistry and Biophysics 82: 70–77. PMID: 13650640.

    Article  PubMed  CAS  Google Scholar 

  35. Kakkar, P., B. Das, and P.N. Viswanthan. 1984. A modified spectrophotometric assay of superoxide dismutase. Indian Journal of Biochemistry & Biophysics 21: 130–132. PMID: 6490072.

    CAS  Google Scholar 

  36. Narendhirakannan, R.T., S. Subramanian, and M. Kandaswamy. 2005. Free radical scavenging activity of Cleome gynandra L. leaves on adjuvant induced arthritis in rats. Molecular and Cellular Biochemistry 276: 71–80. doi:10.1007/s11010-005-3234-6. PMID: 16132687.

    Article  PubMed  CAS  Google Scholar 

  37. Hegen, M., J.C. Keith, M. Collins, and C.L. Nickerson-Nutter. 2008. Utility of animal models for identification of potential therapeutics for rheumatoid arthritis. Annals of the Rheumatic Diseases 67: 1505–1515. PMID: 18055474.

    Article  PubMed  CAS  Google Scholar 

  38. Bevaart, L., M.J. Vervoordeldonk, and P.P. Tak. 2010. Evaluation of therapeutic targets in animal models of arthritis: How does it relate to rheumatoid arthritis? Arthritis and Rheumatism 62: 2192–2205. doi:10.1002/art.27503. PMID: 20506322.

    Article  PubMed  CAS  Google Scholar 

  39. Quinones, M.P., S.K. Ahuja, F. Jimenez, J. Schaefer, E. Garavito, A. Rao, G. Chenaux, R.L. Reddick, W.A. Kuziel, and S.S. Ahuja. 2004. Experimental arthritis in CC chemokine receptor 2-null mice closely mimics severe human rheumatoid arthritis. The Journal of Clinical Investigation 113: 856–866. doi:10.1172/JCI20126. PMID: 15067318.

    PubMed  CAS  Google Scholar 

  40. Altman, A., and F.J. Dixon. 1989. Immunomodifiers in vaccines. Advances in Veterinary Science and Comparative Medicine 33: 301–343. PMID: 2467538.

    PubMed  CAS  Google Scholar 

  41. Crofford, L.J., H. Sano, K. Karalis, E.L. Webster, E.A. Goldmuntz, G.P. Chrousos, and R.L. Wilder. 1992. Local secretion of corticotrophin releasing hormone in the joints of Lewis rats with inflammatory arthritis. The Journal of Clinical Investigation 90: 2555–2564. doi:10.1172/JCI116150. PMID: 1281840.

    Article  PubMed  CAS  Google Scholar 

  42. Linblad, E.B. 2000. Freund’s adjuvants. In Methods in molecular medicine: Vaccine adjuvants—preparation methods and research protocols, ed. D.T. O’ Hagan, 49–63. Totowa: Humana Press.

    Google Scholar 

  43. Cannella, A.C., and J.R. O’Dell. 2003. Is there still a role for traditional disease modifying antirheumatic drugs (DMARDs) in rheumatoid arthritis? Current Opinion in Rheumatology 15: 185–192. PMID: 12707569.

    Article  PubMed  Google Scholar 

  44. Swierkot, J., and J. Szechinski. 2006. Methotrexate in rheumatoid arthritis. Pharmacological Reports 58: 473–492. PMID: 16963793.

    PubMed  CAS  Google Scholar 

  45. Rovensky, J., M. Stancikova, E. Rovenska, S. Stvrtina, V. Stvrtinova, and K. Svik. 2009. Treatment of rat adjuvant arthritis with flavonoid (Detralex), methotrexate, and their combination. Annals of the New York Academy of Sciences 1173: 798–804. doi:10.1111/j.1749-6632.2009.04618.x. PMID: 19758231.

    Article  PubMed  CAS  Google Scholar 

  46. Alastair, G., and M.B. Mowat. 1971. Hematological abnormalities in rheumatoid arthritis. Seminars in Arthritis and Rheumatism 1: 195–219. doi:10.1016/0049-0172(72)90001-7. PMID: 4343443.

    Google Scholar 

  47. Sotnikova, R., S. Ponist, J. Navarova, D. Mihalova, V. Tomekova, M. Strosova, and K. Bauerova. 2009. Effects of sesame oil in the model of adjuvant arthritis. Neuro Endocrinology Letters 30: 22–24. PMID: 20027138.

    PubMed  CAS  Google Scholar 

  48. Ekambaram, S.P., S.S. Perumal, and V. Subramanian. 2011. Assessment of the in-vivo and in-vitro antioxidant potential of Strychnos potatorum Linn. seeds in Freund’s adjuvant induced arthritic rats. Journal of Medicinal Plants Research 5: 4780–4787.

    Google Scholar 

  49. Karatas, F., I. Ozates, H. Canatan, I. Halifeoglu, M. Karatepe, and R. Colakt. 2003. Antioxidant status and lipid peroxidation in patients with rheumatoid arthritis. Indian Journal of Medical Research 118: 178–181. PMID:14700353.

    PubMed  CAS  Google Scholar 

  50. Bauerová, K., S. Poništ, D. Mihalová, F. Dráfi, and V. Kuncírová. 2011. Utilization of adjuvant arthritis model for evaluation of new approaches in rheumatoid arthritis therapy focused on regulation of immune processes and oxidative stress. Interdisciplinary Toxicology 4: 33–39. doi:10.2478/v10102-011-0007-9. PMID: 21577282.

    Article  PubMed  Google Scholar 

  51. Cong, X. D., M. J. Ding, D. Z. Dai, Y. Wu, Y. Zhang, and Y. Dai. 2011. ER Stress, P66shc, and P-Akt/Akt mediate adjuvant-induced inflammation, which is blunted by argirein, a supermolecule and rhein in Rats. Inflammation PMID: 22095404. doi:10.1007/s10753-011-9407-4.

  52. Guerne, P.A., B.L. Zuraw, J.H. Vaughan, D.A. Carson, and M. Lotz. 1989. Synovium as a source of interleukin 6 in vitro: Contribution to local and systemic manifestations of arthritis. The Journal of Clinical Investigation 83: 585–592. doi:10.1172/JCI113921. PMID: 2464001.

    Article  PubMed  CAS  Google Scholar 

  53. Nietfeld, J.J., B. Wilbrink, M. Helle, J.L.A.M. Vanroy, R.W. Denotter, A.J.G. Swaak, and O. Huber-Bruning. 1990. Interleukin-1-induced interleukin-6 is required for the inhibition of proteoglycan synthesis by interleukin-1 in human articular cartilage. Arthritis and Rheumatism 33: 1695–1701. PMID: 2242066.

    Article  PubMed  CAS  Google Scholar 

  54. Deleuran, B.W., C.Q. Chu, M. Field, F.M. Brennan, P. Katsiki, M. Feldmann, and R.N. Maini. 1992. Localization of interleukin-1 a, type 1 interleukin-1 receptor and interleukin-1 receptor antagonist in the synovial membrane and cartilage/pannus junction in rheumatoid arthritis. British Journal of Rheumatology 31: 809–811. doi:10.1093/rheumatology/31.12.801. PMID: 1458286.

    Article  Google Scholar 

Download references

ACKNOWLEDGMENTS

We greatfully acknowledge Dr. S.S.Y Quadri (M.D Pathologist and senior scientist) National Institute of Nutrition, Hyderabad, INDIA for his assistance in preparing and evaluating histopathological slides.

Conflict of Interests

There is no conflict of interests.

Author information

Authors and Affiliations

  1. Department of Pharmaceutical Technology, NSHM Knowledge Campus, 124 B.L. Saha Road, Kolkata, 700053, West Bengal, India

    Souvik Roy & Santanu Sannigrahi

  2. St. Peter’s Institute of Pharmaceutical Sciences, Hanmakonda, Warangal, Andhra Pradesh, 506001, India

    Ram Prasad Vaddepalli

  3. Department of Pharmacology, Medical College Kolkata, West Bengal, Kolkata, 700012, India

    Balaram Ghosh

  4. Galaxy Concept Pvt. Ltd., Behala, Kolkata, 700034, West Bengal, India

    Priyanka Pusp

Authors
  1. Souvik Roy
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Santanu Sannigrahi
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Ram Prasad Vaddepalli
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Balaram Ghosh
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Priyanka Pusp
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Souvik Roy.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Roy, S., Sannigrahi, S., Vaddepalli, R.P. et al. A Novel Combination of Methotrexate and Epigallocatechin Attenuates the Overexpression of Pro-inflammatory Cartilage Cytokines and Modulates Antioxidant Status in Adjuvant Arthritic Rats. Inflammation 35, 1435–1447 (2012). https://doi.org/10.1007/s10753-012-9457-2

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s10753-012-9457-2

KEY WORDS

Search

Navigation